SmartTRAK Life Sciences News and Analysis Blog in the Orthopedics, Wound, and Neuro Therapies Market Segments
.png)
COVID-19 threw a curveball to spine and orthopedic implant companies in 2020 with the downturn in electi...
An initially promising Q4 faltered under the weight of the COVID-19 resurgence, leading to a Q420 WW Spi...
A post-pandemic recovery appears to be on the horizon in the CAS Spine space.
Derrick Johns, President and CEO of DiFusion Technologies, discusses the challenges and opportunities as...
.png)
Ragna Ouwerkerk, PR Manager at Mediq, discusses the Company and its recent acquisitions in an interview ...
While US SCS revenues were almost back to pre-COVID levels in Q320, rising COVID case rates put the brak...
Despite a spike in COVID cases, Soft Tissue Fixation was resilient and managed to ride out the COVID sto...
In an interview with SmartTRAK, Keith Boettiger, VP of Abbott Neuromodulation, discusses the Company’s n...
Healthy growth closes out Q420 as the trauma segment recovers in the second half of the year hitting pre...
Surge in COVID-19 Wipes Out Some Procedural Recovery The surge of COVID-19 cases in Q420 likely brought ...
Login